Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ContinuumRx
AddedFeb 15, 2024
UpdatedJun 18, 2026
ContinuumRx

ContinuumRx

Acquired

ContinuumRx: A nationwide provider of home infusion and medication services, ensuring comprehensive patient care.

HQ
Birmingham, AL, US
Founded
2001
Overview
Compare
Fundraising
Employees
Website

Founded over twenty years ago, ContinuumRx is a nationwide provider of home infusion and medication services. The company’s core mission is to deliver comprehensive patient care through its network of pharmacists, nurses, registered dietitians, and pharmaceutical companies. ContinuumRx offers a range of services including antibiotic therapy, enteral and parenteral nutrition, IVIG therapy, heart failure therapy, and biologic therapies. Their market focus extends across the United States, providing essential healthcare services directly to patients' homes.

Notable affiliates include a network of healthcare professionals and partnerships with various pharmaceutical companies. ContinuumRx has achieved significant milestones in improving patient outcomes and expanding access to home-based healthcare solutions. Their impact is evident in the enhanced quality of life for patients who require complex medical treatments outside of traditional hospital settings. Through continuous innovation and dedication to patient care, ContinuumRx has established itself as a leader in the home infusion industry.

ContinuumRx - Quick Facts

When was ContinuumRx founded?

ContinuumRx was founded in 2001.

Where is ContinuumRx's headquarters located?

ContinuumRx's headquarters is located in Birmingham, AL, US.

When was ContinuumRx's last funding round?

ContinuumRx's most recent funding round was for $13.5M (USD) in July 2015.

How much has ContinuumRx raised to-date?

As of Jul 21, 2015, ContinuumRx has raised a total of $20.5M (USD).

ContinuumRx - Classification

Industry
  • Professional Service Companies
Technology
  • Telemedicine
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Home Infusion
  • Medication Services
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 7 more industry codes
NAICS
  • 456000Health and Personal Care Retailers
  • 450000Retail Trade
  • 623000Nursing and Residential Care Facilities
  • 456100Health and Personal Care Retailers
  • 456110Pharmacies and Drug Retailers
SIC
  • 5900Miscellaneous Retail
  • 5910Drug Stores And Proprietary Stores